Ovid Therapeutics
OVID
$3.07
Share price
0.33%
Change (1 day)
-15.43%
Change (1 year)
Categories
Ovid Therapeutics (OVID) - P/B ratio
P/B ratio as of May 2024 : 2.47
According to Ovid Therapeutics
's latest financial reports the company has a price-to-book ratio of 2.47.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ovid Therapeutics - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.59 | 161.61% |
| 2022-12-31 | 0.9909 | -18.51% |
| 2021-12-31 | 1.22 | -63.79% |
| 2020-12-31 | 3.36 | 3.58% |
| 2019-12-31 | 3.24 | 110.89% |
| 2018-12-31 | 1.54 | -47.17% |
| 2017-12-31 | 2.91 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.81 | 13.74% | 🇺🇸 USA |